Rami Levy - INC Research Chief Canndoc
| INCR Stock | USD 1.35 0.09 6.25% |
Insider
Rami Levy is Chief Canndoc of INC Research Holdings
| Age | 59 |
| Address | 85 Medinat ha-Yehudim Street, Herzliya, Israel, 4676670 |
| Phone | 972 7 746 05012 |
| Web | https://www.intercure.co |
INC Research Management Efficiency
As of 11/28/2024, Return On Tangible Assets is likely to drop to -0.12. In addition to that, Return On Capital Employed is likely to grow to -0.07. At this time, INC Research's Total Assets are relatively stable compared to the past year. As of 11/28/2024, Non Current Assets Total is likely to grow to about 386.2 M, while Return On Tangible Assets are likely to drop (0.12). INC Research's management efficiency ratios could be used to measure how well INC Research manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| YatGai Au | Regencell Bioscience Holdings | 51 | |
| III CPA | Pacira BioSciences, | 61 | |
| Eric Offenberger | Vext Science | N/A | |
| Scott Sudduth | Collegium Pharmaceutical | N/A | |
| Aaron Miles | Verano Holdings Corp | 44 | |
| Stephan Bankosz | Vext Science | N/A | |
| John Tipton | Verano Holdings Corp | 62 | |
| Daryl Gaugler | Pacira BioSciences, | 62 | |
| Jeff Finnerty | AYR Strategies Class | N/A | |
| Madhukar Bhalla | Incannex Healthcare Ltd | 65 | |
| Paul Fisher | AYR Strategies Class | N/A | |
| Adel Mekhail | Prestige Brand Holdings | 63 | |
| BSc EMBA | Incannex Healthcare Ltd | N/A | |
| Michelle Chan | Regencell Bioscience Holdings | N/A | |
| Julianna CFA | Verano Holdings Corp | N/A | |
| Wai Chung | Regencell Bioscience Holdings | 47 | |
| George Archos | Verano Holdings Corp | 44 | |
| Mark Bleackley | Incannex Healthcare Ltd | N/A | |
| Jean Filippi | Phibro Animal Health | N/A | |
| Damian Finio | Phibro Animal Health | 54 | |
| Jonathan MD | Pacira BioSciences, | 49 | |
Management Performance
| Return On Equity | -0.14 | ||||
| Return On Asset | -0.0024 |
INC Research Holdings Leadership Team
Elected by the shareholders, the INC Research's board of directors comprises two types of representatives: INC Research inside directors who are chosen from within the company, and outside directors, selected externally and held independent of INC. The board's role is to monitor INC Research's management team and ensure that shareholders' interests are well served. INC Research's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, INC Research's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Alexander Rabinovich, CEO Director | ||
| Amos Cohen, Chief Officer | ||
| Alexander Rabinovitch, CEO Director | ||
| Advocate Ohayon, CoFounder Ltd | ||
| Einat Zehavi, Vice Sales | ||
| OriMoni Mimon, CoFounder Ltd | ||
| Omri Batzir, Corporate Controller | ||
| Rami Levy, Chief Canndoc |
INC Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is INC Research a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.14 | ||||
| Return On Asset | -0.0024 | ||||
| Profit Margin | (0.24) % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 97.58 M | ||||
| Shares Outstanding | 45.77 M | ||||
| Shares Owned By Insiders | 39.59 % | ||||
| Shares Owned By Institutions | 11.61 % | ||||
| Number Of Shares Shorted | 16.23 K | ||||
| Price To Earning | 37.77 X |
Pair Trading with INC Research
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if INC Research position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INC Research will appreciate offsetting losses from the drop in the long position's value.Moving together with INC Stock
| 0.74 | FDMT | 4D Molecular Therapeutics | PairCorr |
| 0.86 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.87 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
Moving against INC Stock
| 0.88 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
| 0.84 | NAMS | NewAmsterdam Pharma | PairCorr |
| 0.47 | PMVP | Pmv Pharmaceuticals | PairCorr |
| 0.46 | PHVS | Pharvaris BV | PairCorr |
| 0.37 | ESLAW | Estrella Immunopharma | PairCorr |
The ability to find closely correlated positions to INC Research could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace INC Research when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back INC Research - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling INC Research Holdings to buy it.
The correlation of INC Research is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as INC Research moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if INC Research Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for INC Research can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for INC Stock Analysis
When running INC Research's price analysis, check to measure INC Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INC Research is operating at the current time. Most of INC Research's value examination focuses on studying past and present price action to predict the probability of INC Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INC Research's price. Additionally, you may evaluate how the addition of INC Research to your portfolios can decrease your overall portfolio volatility.